1991). Patients receiving human chorionic gonadotrophin
NY, USA (HCG) for luteal support are also at an increased risk (Smitz 4 To whom correspondence should be addressed et al., 1988; Forman et al., 1990) . It has been concluded that In-vitro fertilization patients (n ⍧ 15) at risk of ovarian development of this syndrome is limited to cycles with exposure hyperstimulation syndrome (OHSS) (oestradiol ജ4500 pg/ to endogenous or exogenous HCG (Schenker and Weinstein, ml on the day of human chorionic gonadotrophin adminis-1978; Navot et al., 1992) . Consequently, the most effective tration and 25 or more follicles of intermediate or large size) prevention is to avoid pregnancy via cycle cancellation and underwent aspiration of all follicles and cryopreservation of the withholding of HCG (Smitz et al., 1988) . Although the all fertilized oocytes at the pronuclear stage. Patients were safest approach, cycle cancellation is frustrating and costly to monitored for up to 2 weeks post-retrieval. Subsequent the infertile patient.
transfer of cryopreserved-thawed embryos was performed
One approach which minimizes HCG exposure without in programmed cycles using exogenous oestrogen and forfeiting oocyte retrieval was described by Amso et al. (1990) . progesterone for endometrial preparation. Two patients
Oocyte retrieval was performed with elective cryopreservation (13%) developed OHSS necessitating hospitalization and of all resulting pre-embryos. Avoiding fresh embryo vaginal aspiration of ascitic fluid. Two other patients (13%) transfer minimized further HCG exposure during the cycle at developed moderate OHSS requiring ascitic fluid vaginal risk and all participants subsequently conceived from thawed aspiration in the office setting, with dramatic improvement embryo transfer. Based on this approach, we adopted a strategy of the condition. Subsequent transfer of cryopreservedto identify prospectively patients at risk for severe thawed embryos yielded a clinical pregnancy rate of 58% OHSS, minimize their exposure to HCG, and not compromise per transfer and ongoing or delivery rates of 42 and 67% their chances of pregnancy from oocytes developed within that per transfer and per patient respectively. By eliminating cycle. Starting in 1992, we sought to reduce the incidence of pregnancy potential with cryopreservation of all prezygotes severe OHSS using the following steps. Patients at risk and examining the pregnancy potential with subsequent were identified before HCG administration by specific serum cryopreserved-thawed transfers, it is concluded that OHSS oestradiol and ultrasound criteria, ovulation was triggered with is reduced, but not eliminated for patients at risk. Suba reduced HCG dose, retrieval was followed by cryopreservsequent transfer of cryopreserved-thawed prezygotes in a ation of all pre-embryos and the patients observed pelvic rest programmed cycle with exogenous steroids yields an excelfor 2 weeks. lent pregnancy rate.
Introduction
Materials and methods One of the primary goals of assisted reproductive technology Subjects (ART) is to achieve some degree of ovarian stimulation.
A total of 15 infertile patients who underwent ovarian stimulation However, too vigorous a response can lead to ovarian hyperfor in-vitro fertilization (IVF)/embryo transfer between November stimulation syndrome (OHSS) which is a potentially life-1992 and February 1995 were identified as high risk for developing threatening iatrogenic complication. The incidence of severe severe OHSS. Of these 15 patients, nine had tubal infertility, three had abnormal semen parameters and three suffered from unexplained OHSS is only 1-2% (Golan et al., 1989; Smitz et al., 1990) , and progesterone (50 mg i.m. daily) were maintained. Patients were weaned from exogenous steroids once placental autonomy was determined by weekly serum oestradiol and progesterone monitoring. infertility. All patients received luteal phase GnRHa (Lupron; TAP Pregnant patients were asked to have a pelvic ultrasound 4-6 weeks Pharmaceuticals, Abbott Park, IL, USA). Ovarian stimulation was after transfer to determine viability and check for multiple gestations. performed using human menopausal gonadotrophin (HMG) or follicle stimulating hormone (FSH), alone or in combination (Pergonal and Metrodin; Serono Laboratories, Randolph, MA, USA) by a protocol previously described (Muasher et al., 1991) . Oestradiol concentrations yielding 3500 and 1250 ml, respectively. Hospitalization lasted performed in this group of patients. All pre-embryos which sub-5 and 3 days respectively, with dramatic relief occurring after sequently arose from mature oocytes were cryopreserved at the fluid aspiration in both patients. Two patients developed pronuclear stage. All patients were given warnings for severe OHSS moderate OHSS with moderate ovarian enlargement (7-10 cm and were followed carefully for up to 2 weeks post-retrieval. Patients by ultrasound), moderate haemoconcentration (haematocrit 45-were asked to perform surveillance by daily weight measurements 50), hypovolaemia, and ascites. Both were followed daily with using the same scale, daily abdominal girth measurements, and in monitoring of abdominal girth, weight, and urine output. These some cases, urine volumes were recorded daily. Each patient was two patients had transvaginal aspiration of 1200 and 650 ml asked to observe strict pelvic rest for 2 weeks. A summary of patient of ascitic fluid respectively. This procedure was performed in characteristics and stimulation cycle outcome is presented in Table I. the office setting and hospitalization was not required. All Thawed embryo transfer protocol remaining patients who experienced moderate discomfort were Cryopreservation was performed using a slow freeze, slow thaw treated symptomatically with bed rest and analgesics. Sympprotocol (Veeck et al., 1993) . Patients receiving thawed embryo toms resolved without further intervention.
transfer underwent a protocol of endometrial preparation using After a minimum interval of 2 months following retrieval, exogenous steroids according to Muasher et al. (1991) . Briefly, all all 15 patients returned for thawed embryo transfer and the patients had a minimum interval of 2 months separating their results are presented in Table II . To date, 24 frozen-thaw stimulation and thawed embryo transfer. GnRHa suppression was transfers have been performed for these patients. The postachieved using leuprolide acetate (0.5 mg/day s.c.) 2-3 weeks thaw survival rate was 74%, which is consistent with our prior after menstruation. Transdermal oestradiol patches (Estraderm ® ; Ciba experience (Queenan et al., 1995) . The mean number of prePharmaceuticals, Summit, NJ, USA) were administered with the onset embryos transferred per patient was 3.8, which was thought of menses. The leuprolide acetate was discontinued on cycle day 15 and daily administration of progesterone in oil (50 mg i.m.) was to be a conservative figure, considering that, in our experience, initiated. Pre-embryos were thawed on day 16 and transferred on day frozen-thawed embryo transfers usually have a lower implanta-17 after evidence of syngamy and cleavage confirmed viability. tion rate than fresh transfers, and that the number of embryos Thawing of pre-embryos was performed in the biological freezer transferred is currently only subject to voluntary limits in the and then thawed specimens were taken through a series of decreasing US. The rate of clinical pregnancy per transfer was 58% (14/ concentrations of 1,2-propanediol for 5 min at each dilution (1.0, 24). The rate of ongoing gestation Ͼ20 weeks or live delivery 0.5 M, and Dulbecco's phosphate-buffered saline without cryoprotectper transfer was 42% (10/24). There were no multiple ant). Each specimen was transferred to equilibrated Ham's F-10 gestations.
culture medium (Gibco Laboratories, Grand Island, New York, USA)
The rate of ongoing pregnancy or delivery per patient was containing 15% human fetal cord serum. Incubation at 37°C under 67% (10/15). There is reason to anticipate that this rate 5% CO 2 in air was performed until a cleavage pattern was ascertained will continue to increase over time. Ten patients still have (Veeck et al., 1993) .
If pregnancy was confirmed by serum quantitative β-HCG 13 days cryopreserved pre-embryos remaining (mean ϭ 12 per patient).
Cryopreservation of all prezygotes in OHSS Discussion thawed embryo transfer protocol which we have previously reported (Queenan et al., 1994) . Our findings are similar to No method of treatment has been able to eradicate severe those of Frederick et al. (1995) in that our steroid prepared OHSS from the practice of ART. Prevention of OHSS remains thaw transfer protocol has achieved a 30% clinical pregnancy the best strategy for the practitioner. One approach is through rate (70/230) compared with this subpopulation that have a identification of those at risk before triggering ovulation. 58% pregnancy rate under the same transfer protocol. The During ovarian stimulation, a large cohort of intermediate and possibility that these embryos are of a higher quality is large follicles is a widely accepted risk factor for OHSS (Tal intriguing , but further studies and greater numbers are needed et al., 1985; Blankstein et al., 1987) . Once identified, the HCG to confirm this observation. dose can be withheld, delayed or reduced. It should be
We believe the protocol presented identifies patients early remembered that severe OHSS is a potentially lethal iatrogenic and is somewhat aggressive in its approach. All patients complication of ART which can only truly be prevented when received HCG and no cycles were cancelled. Further modifica-HCG is withheld. Our approach was to minimize endogenous tions could possibly lessen the incidence of severe OHSS, and exogenous HCG exposure. We reduced the HCG dose at such as i.v. albumin (Asch et al., 1993) or avoiding HCG by ovulatory trigger by 50% and avoided HCG for luteal support.
the use of GnRHa to stimulate an endogenous luteinizing The patients were not exposed to endogenous HCG since no hormone (LH) surge (Imoedemhe et al., 1991) . The embryos fresh transfer was performed. OHSS occurs less often in that resulted proved to be of very high quality. The chances patients given 5000 IU of HCG compared with those receiving for future live births are excellent with transfer of thawed a higher dose (Schenker, 1995) . We treated all patients at risk embryos using a programmed cycle with exogenous steroids. with this reduced dose of HCG. When severe OHSS was encountered, we aggressively performed early transvaginal aspiration of ascitic fluid. In our experience, this provides References instant symptomatic relief and decreases the chance of hospitalAmso, N.N., Ahuja, K.K., Morris, N. and Shaw, R.W. (1990) The management ization or length of stay. We feel this step should be considered of predicted ovarian hyperstimulation involving gonadotropin-releasing in all stable patients without severe coagulation disorder. occurs in a significant number of patients (Salat-Baroux et al., Asch, R.H., Ivery, G., Goldsman, M. et al. (1993) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation 1990); however, Wada et al. (1992) have suggested that the syndrome. Hum. Reprod., 8, 1015 Reprod., 8, -1019 severity of symptoms is reduced. In our programme, the Blankstein, J., Shalev, J., Saadon, T. et al. (1987) Ovarian hyperstimulation reduced amount of β-HCG given to trigger ovulation (5000 IU) syndrome: prediction by number and size of preovulatory follicles. Fertil. Steril., 47, [597] [598] [599] [600] [601] [602] was sufficient to allow development of severe OHSS in two Forman, R.G., Frydman, R., Egan, D. et al. (1990) Severe ovarian out of 15 (13%) patients at high risk. In a similar protocol, hyperstimulation syndrome using agonists of gonadotropin-releasing Wada et al. (1992) reported 27% developed OHSS after hormone for in vitro fertilization: a European series and a proposal for retrieval and cryopreservation, 7% having the severe form of prevention. Fertil. Steril., 53, 502-509. Forman, R., Fries, N., Testart, J. et al. (1988) Evidence for an adverse effect this disease. Pattinson et al. (1994) achieved a 1.4% rate of of elevated serum estradiol concentrations on embryo implantation. Fertil.
severe OHSS through cycle cancellation in patients at highest Steril., 49, [118] [119] [120] [121] [122] risk or cryopreservation when patients were at moderate risk. a poor chance for conception (Gidley-Baird et al., 1986;  Golan, A., Ron-El, R., Soffer, Y. et al. (1989) Ovarian hyperstimulation Forman et al., 1988) . Through the experience with cryopreservsyndrome: an update review. Obstet. Gynecol. Surv., 44, [430] [431] [432] [433] [434] [435] [436] [437] [438] [439] [440] ation and oocyte donation, it is now known that egg quality Imoedemhe, D.A.G., Sigue, A.B., Pacpaco, E.L.A. and Olazo, A.B. (1991) is not harmed in a hyperstimulated cycle. Cryopreservation Stimulation of endogenous surge of luteinizing hormone with gonadotropinreleasing hormone analog after ovarian stimulation for in vitro fertilization.
gives the opportunity to defer pregnancy and conserve preg- Fertil. Steril., 55, nancy potential in the form of stored embryos.
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